Deepak Nitrite
- Market Cap
- ₹20,885 Cr
- P/E
- 19.66
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 11.40%
- Debt to Equity
- 0.27
- EPS (TTM)
- ₹77.89
- Book Value
- ₹474.73
- Market Cap
- ₹20,885 Cr
- P/E (TTM)
- 19.66
- P/B
- 3.23
- ROE
- 9.82%
- Dividend Yield
- 0.48%
- EBITDA
- ₹1,041 Cr
- 52W High
- ₹1,897.90
- 52W Low
- ₹1,280.00
- Day Range
- ₹1,524.90 – ₹1,555.30
- Volume
- 2,32,572
Peer Comparison
Commodities › Chemicals & Petrochemicals › Specialty Chemicals
| 1,620.00 | 61.46 | 1,64,897 | 14.71 | 1.41% | 23.90% | 31.00% | 16,142 | 2,718 | |
| 4,932.70 | 80.98 | 54,186 | 6.46 | 0.06% | 7.82% | 9.64% | 5,853 | 661 | |
| 10,077.00 | 56.75 | 51,687 | 11.58 | 0.08% | 19.80% | 21.00% | 4,066 | 910 | |
| 1,620.30 | 86.28 | 21,506 | 8.29 | 0.00% | 9.66% | 11.90% | 1,298 | 249 | |
| 1,531.20 | 19.66 | 20,885 | 3.23 | 0.48% | 9.82% | 11.40% | 9,749 | 1,063 | |
| 5,488.50 | 34.93 | 16,828 | 5.74 | 0.20% | 16.60% | 21.50% | 2,604 | 481 | |
| 449.50 | 27.49 | 16,299 | 2.60 | 0.22% | 7.17% | 6.86% | 10,579 | 593 | |
| Median 7 companies | 1,620.30 | 56.75 | 21,506 | 6.46 | 0.20% | 9.82% | 11.90% | 5,853 | 661 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 48
- Average
- Returns, margins, earnings quality 22% weight
- Valuation
- 57
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 88
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 63
- Good
- Solvency, leverage, coverage 9% weight
- Momentum
- 29
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 39
- Weak
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
2- Company has a low return on equity of 12.9% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 5 | 3 |
| Oscillators | Bullish | 1 | 5 | 3 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 45.38
- Neutral
- MACD (12,26,9)
- 2.17
- Bullish
- SMA (50)
- 1,560.68
- Bearish
- SMA (200)
- 1,620.09
- Bearish
As of
Analyst Rating
11 of 15 analysts rate Buy, 0 Hold, 4 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +19.10% |
|---|---|
| 5Y | +12.59% |
| 3Y | −0.36% |
| 1Y | −4.77% |
| TTM | +23.80% |
Net profit
| 10Y | +24.22% |
|---|---|
| 5Y | −6.62% |
| 3Y | −13.52% |
| 1Y | −20.95% |
| TTM | +100.19% |
Operating cash flow
| 10Y | +12.43% |
|---|---|
| 5Y | −11.66% |
| 3Y | −6.05% |
| 1Y | −13.76% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +0.20 pp |
|---|---|
| 5Y | −16.21 pp |
| 3Y | −3.70 pp |
| 1Y | −0.71 pp |
| TTM | +6.82 pp |
Revenue by year
| Mar 2017 | ₹1,371 Cr |
|---|---|
| Mar 2018 | ₹1,651 Cr |
| Mar 2019 | ₹2,700 Cr |
| Mar 2020 | ₹4,230 Cr |
| Mar 2021 | ₹4,360 Cr |
| Mar 2022 | ₹6,802 Cr |
| Mar 2023 | ₹7,972 Cr |
| Mar 2024 | ₹7,682 Cr |
| Mar 2025 | ₹8,282 Cr |
| Mar 2026 | ₹7,887 Cr |
Net profit by year
| Mar 2017 | ₹96.00 Cr |
|---|---|
| Mar 2018 | ₹79.00 Cr |
| Mar 2019 | ₹174 Cr |
| Mar 2020 | ₹611 Cr |
| Mar 2021 | ₹776 Cr |
| Mar 2022 | ₹1,067 Cr |
| Mar 2023 | ₹852 Cr |
| Mar 2024 | ₹811 Cr |
| Mar 2025 | ₹697 Cr |
| Mar 2026 | ₹551 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Deepak Nitrite Ltd trades at ₹1,590.1 with a market cap of ₹21,688 Cr and a P/E of 20.41x as of 2026-11-17. The company shows a sharp TTM profit recovery of 102% after several years of profit contraction, while carrying modest debt with a debt-to-equity ratio of 0.28.
- TTM profit growth of 102% signals a strong earnings recovery after a prolonged downcycle where 3-year and 5-year compounded profit growth stood at -13% and -7% respectively
- TTM sales growth of 24% indicates a meaningful revenue acceleration compared to the flat 0% compounded sales growth over the past 3 years
- Long-term compounded sales growth of 19% over 10 years demonstrates a durable business franchise with consistent top-line expansion
- 10-year compounded profit growth of 24% and 10-year stock CAGR of 33% reflect substantial long-term value creation for shareholders
- Conservative balance sheet with a debt-to-equity ratio of just 0.28 provides financial flexibility for future capacity expansion or to weather commodity cycles
- Current price of ₹1,590.1 is roughly 16% below the 52-week high of ₹1,897.9, offering a potential entry closer to mid-range of the 52-week band (₹1,280–₹1,897.9)
- The company is expected to deliver a good upcoming quarter, suggesting near-term operational momentum may sustain the TTM earnings recovery trend
- 10-year average ROE of 20% highlights the company's historical ability to generate strong returns on shareholder capital over full business cycles
- 3-year compounded profit growth of -13% and 5-year compounded profit growth of -7% indicate a prolonged earnings contraction that the TTM recovery has only begun to reverse
- Current ROE of 9.38% and last-year ROE of 10% are well below the 10-year average of 20%, suggesting return on capital has structurally declined from peak levels
- 3-year average ROE of approximately 12.9% is low for a specialty chemicals company, indicating sub-par capital efficiency during recent years
- Stock CAGR of -10% over 3 years and -7% over 5 years shows the stock has destroyed value for medium-term investors despite the broader market rally
- Potential capitalisation of interest costs could be flattering reported profitability and understating the true cost structure, making the P/E of 20.41x appear cheaper than underlying economics warrant
- Dividend yield of just 0.47% offers minimal income cushion, leaving total returns almost entirely dependent on capital appreciation
- Price-to-book ratio of 3.35x is elevated relative to the current ROE of 9.38% and ROCE of 10.85%, implying the market is pricing in a recovery that must materialise to justify the valuation
- As a commodities-sector company, earnings are inherently cyclical and the sharp 102% TTM profit jump may reflect a cyclical peak rather than a sustainable new baseline
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Deepak Nitrite delivered a standout Q2 FY27 with profit tripling and its Phenolics segment hitting record profitability, driven by favourable domestic supply dynamics and strong execution. The new Dahej plant and planned polycarbonate expansion add medium-term growth levers. Key risks include a still-negative YTD stock performance, sequential margin softness, and a volatile global cost environment. The operational trend is strongly improving, but sustaining these tailwinds beyond the current import-disruption cycle remains the key watch item.
- Stock down ~11% year-to-date Oct 29
Despite strong Q2 results, shares remain under pressure with a 10.77% decline year-to-date, suggesting broader market or sectoral headwinds.
- Volatile global operating environment Oct 29
The company flagged geopolitical tensions, disrupted trade flows, feedstock constraints and elevated logistics costs as ongoing challenges to navigate.
- Sequential gross margin decline Oct 29
Gross margin fell 200 basis points quarter-on-quarter despite a 730 bps YoY improvement, hinting at emerging cost or pricing pressure on a sequential basis.
- Q2 profit triples, EBITDA up 207% Oct 29
Consolidated net profit tripled to ₹398 crore from ₹118.7 crore YoY in Q2 FY27, while EBITDA jumped 207% to ₹627 crore and margin nearly doubled to 20.4% from 10.7%.
- Phenolics delivers best-ever quarter Oct 29
Phenolics revenue rose 72% YoY to ₹2,291 crore with EBIT surging 256% to ₹515 crore. H1 FY27 EBIT of ₹933 crore already surpassed the previous full-year peak of ₹867 crore in FY22.
- Revenue surges 62% YoY Oct 29
Revenue from operations grew 61.7% to ₹3,076 crore from ₹1,901.9 crore, driven by strong domestic demand, tighter import supply and firm realisations.
- Phenolics acquires ₹124cr Chem Tech stake Nov 20
Deepak Phenolics invested ₹124 crore in Deepak Chem Tech via OCRPS at ₹100/share on November 20, 2026, for project expenses and general corporate purposes. Deepak Chem Tech turnover rose to ₹172.23 crore in FY26 from ₹9.43 crore in FY25.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,778 | 2,009 | 2,126 | 2,167 | 2,032 | 1,903 | 2,180 | 1,890 | 1,902 | 1,975 | 2,120 | 2,578 | 3,076 |
| Expenses | 1,476 | 1,705 | 1,825 | 1,858 | 1,734 | 1,735 | 1,863 | 1,700 | 1,698 | 1,764 | 1,744 | 2,037 | 2,450 |
| Operating Profit | 302 | 305 | 301 | 309 | 298 | 169 | 317 | 190 | 204 | 211 | 376 | 540 | 627 |
| OPM % | 17% | 15% | 14% | 14% | 15% | 9% | 15% | 10% | 11% | 11% | 18% | 21% | 20% |
| Other Income | 17 | 14 | 99 | 19 | 21 | 21 | 23 | 25 | 20 | −4 | 7 | 14 | 16 |
| Interest | 3 | 3 | 4 | 6 | 6 | 6 | 9 | 8 | 8 | 11 | 19 | 23 | 29 |
| Depreciation | 39 | 42 | 46 | 47 | 48 | 48 | 51 | 51 | 53 | 58 | 63 | 64 | 71 |
| PBT | 277 | 274 | 349 | 275 | 264 | 135 | 279 | 155 | 163 | 138 | 301 | 468 | 543 |
| Tax % | 26% | 26% | 27% | 26% | 26% | 27% | 27% | 27% | 27% | 28% | 27% | 26% | 27% |
| Net Profit | 205 | 202 | 254 | 203 | 194 | 98 | 202 | 112 | 119 | 100 | 220 | 345 | 398 |
| EPS (₹) | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 | 14.84 | 8.23 | 8.70 | 7.32 | 16.11 | 25.30 | 29.16 |
| YoY Sales growth | −9 | 1 | 8 | 23 | 14 | −5 | 3 | −13 | −6 | 4 | −3 | 36 | 62 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,327 | 1,373 | 1,371 | 1,651 | 2,700 | 4,230 | 4,360 | 6,802 | 7,972 | 7,682 | 8,282 | 7,887 | 9,749 |
| Expenses | 1,187 | 1,204 | 1,231 | 1,447 | 2,278 | 3,194 | 3,108 | 5,196 | 6,680 | 6,555 | 7,187 | 6,900 | 7,995 |
| Operating Profit | 140 | 169 | 139 | 204 | 421 | 1,035 | 1,252 | 1,607 | 1,292 | 1,127 | 1,095 | 987 | 1,754 |
| OPM % | 11% | 12% | 10% | 12% | 16% | 24% | 29% | 24% | 16% | 15% | 13% | 13% | 18% |
| Other Income | 1 | 0 | 80 | 7 | 11 | 29 | 20 | 42 | 46 | 156 | 84 | 44 | 33 |
| Interest | 38 | 40 | 37 | 47 | 87 | 118 | 77 | 36 | 27 | 15 | 31 | 49 | 82 |
| Depreciation | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 195 | 225 | 255 |
| PBT | 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 953 | 757 | 1,450 |
| Tax % | 21% | 29% | 28% | 29% | 35% | 24% | 26% | 26% | 26% | 26% | 27% | 27% | — |
| Net Profit | 53 | 63 | 96 | 79 | 174 | 611 | 776 | 1,067 | 852 | 811 | 697 | 551 | 1,062 |
| EPS (₹) | 5.06 | 5.39 | 7.37 | 5.79 | 12.73 | 44.80 | 56.88 | 78.20 | 62.47 | 59.45 | 51.12 | 40.36 | 77.89 |
| Div. Payout % | 20% | 22% | 16% | 22% | 16% | 10% | 10% | 9% | 12% | 13% | 15% | 19% | — |
| Sales growth | — | 3 | 0 | 20 | 63 | 57 | 3 | 56 | 17 | −4 | 8 | −5 | 24 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,361 | 5,810 | 6,448 |
| Borrowings | 545 | 529 | 724 | 987 | 1,187 | 1,107 | 590 | 315 | 73 | 286 | 1,267 | 1,638 | 1,762 |
| Other Liabilities | 235 | 295 | 350 | 684 | 677 | 538 | 630 | 779 | 967 | 1,012 | 1,053 | 1,180 | 1,575 |
| Total Liabilities | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 8,654 | 9,814 |
| Fixed Assets | 549 | 594 | 586 | 588 | 1,716 | 1,832 | 1,864 | 1,963 | 1,942 | 2,293 | 2,457 | 3,270 | 4,237 |
| CWIP | 44 | 36 | 349 | 955 | 34 | 172 | 220 | 122 | 301 | 774 | 1,649 | 1,828 | 1,299 |
| Investments | 3 | 87 | 118 | 32 | 2 | 2 | 189 | 439 | 379 | 122 | 511 | 213 | 331 |
| Other Assets | 530 | 580 | 736 | 1,018 | 1,183 | 1,210 | 1,293 | 1,908 | 2,508 | 2,907 | 3,091 | 3,343 | 3,946 |
| Total Assets | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 8,654 | 9,814 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 108 | 167 | 49 | 183 | 60 | 765 | 1,002 | 824 | 650 | 874 | 625 | 539 |
| Investing | −89 | −169 | −353 | −525 | −163 | −428 | −396 | −424 | −276 | −717 | −1,489 | −669 |
| Financing | −22 | 4 | 305 | 345 | 96 | −338 | −599 | −386 | −359 | 44 | 806 | 193 |
| Net Cash Flow | −3 | 2 | 1 | 4 | −6 | −1 | 7 | 14 | 15 | 200 | −59 | 64 |
| Free Cash Flow | 18 | 81 | −192 | −438 | −194 | 349 | 788 | 638 | 290 | 110 | −494 | −658 |
| CFO/EBITDA | 87 | 110 | 47 | 103 | 28 | 93 | 99 | 73 | 70 | 101 | 77 | 74 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 83 | 96 | 91 | 78 | 53 | 63 | 61 | 60 | 62 | 56 | 70 |
| Inventory Days | 47 | 54 | 75 | 118 | 94 | 63 | 64 | 53 | 62 | 54 | 59 | 57 |
| Days Payable | 48 | 59 | 95 | 176 | 106 | 57 | 72 | 46 | 46 | 38 | 33 | 35 |
| Cash Conversion Cycle | 85 | 79 | 76 | 32 | 66 | 59 | 56 | 67 | 76 | 77 | 82 | 92 |
| Working Capital Days | −3 | −28 | −49 | −29 | 35 | 33 | 57 | 57 | 70 | 70 | 64 | 61 |
| ROCE % | — | 14% | 8% | 10% | 17% | 38% | 40% | 44% | 30% | 22% | 16% | 11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Deepak Nitrite insights
64 extracted metrics across FY12–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026Transcript PPT Recording
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- 12 Nov 2025
- 27 Aug 2026
- 11 Aug 2025
- 28 Mar 2025
- 11 Mar 2024
- 2 Jun 2023
Frequently Asked Questions about Deepak Nitrite
What does Deepak Nitrite Ltd do?
Where is Deepak Nitrite Ltd (DEEPAKNTR) listed?
Which sector does Deepak Nitrite Ltd belong to?
What is the market capitalisation of Deepak Nitrite Ltd?
What is the PE ratio of Deepak Nitrite Ltd?
What is the 52-week high and low of Deepak Nitrite Ltd?
Does Deepak Nitrite Ltd pay dividends?
What is the Return on Equity (ROE) of Deepak Nitrite Ltd?
Company Information
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine & Speciality Chemicals, Performance Products, and Phenolics
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DEEPAKNTR.md for Deepak Nitrite Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.